US Broker Ratings

Edgewise Therapeutics, Inc. (EWTX) Stock Analysis: A 39% Potential Upside in the Biotech Sector

Edgewise Therapeutics, Inc. (NASDAQ: EWTX), a promising player in the biotechnology sector, presents an intriguing opportunity for investors focused on innovative healthcare solutions. With a market capitalization of $2.9 billion,..

Select Medical Holdings Corp (SEM) Stock Analysis: Unpacking a 19.79% Potential Upside

Select Medical Holdings Corporation (NYSE: SEM), a significant player in the healthcare sector, has captured investor attention with its robust growth potential and operational footprint across the United States. As..

Denali Therapeutics Inc. (DNLI)

⚠️ No article content returned.

..

BioCryst Pharmaceuticals, Inc. (BCRX): Investor Outlook with 207% Potential Upside

BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX), a notable player in the healthcare sector, is making waves with its promising pipeline and remarkable potential upside. Specializing in the development of oral small-molecule..

Progyny, Inc. (PGNY) Stock Analysis: Unpacking a 24% Upside Potential in the Fertility Benefits Sector

Progyny, Inc. (NASDAQ: PGNY) continues to capture the attention of investors with its innovative approach to fertility and family-building benefits. As a healthcare plans provider specializing in fertility solutions, Progyny..

Kymera Therapeutics, Inc. (KYMR) Stock Analysis: A 67.91% Potential Upside with Strong Buy Ratings

Kymera Therapeutics, Inc. (NASDAQ: KYMR) has captured investor attention with its innovative approach in the biotechnology sector. This clinical-stage biopharmaceutical company, headquartered in Watertown, Massachusetts, is pioneering in the field..

HUTCHMED (China) Limited (HCM): Investor Outlook on a 39.47% Upside in the Growing Oncology Market

HUTCHMED (China) Limited (NASDAQ: HCM), a prominent player in the healthcare sector, is making waves in the pharmaceutical industry with its innovative approach to cancer treatment. With a market capitalization..

Ligand Pharmaceuticals (LGND) Stock Analysis: A Biotech Leader with 26% Upside Potential

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) is making waves in the biotechnology sector with its robust pipeline and promising valuation metrics. With a market capitalization of $3.8 billion, this U.S.-based biotech..

Harmony Biosciences Holdings, Inc. (HRMY): Growth Prospects and a 27% Upside Potential

Harmony Biosciences Holdings, Inc. (NASDAQ: HRMY) is capturing investor attention with its solid growth trajectory and promising pipeline in the biotechnology sector. With a market capitalization of $2.09 billion, the..

Addus HomeCare Corporation (ADUS): Investor Outlook Highlights Strong Growth Potential with 31.16% Upside

Addus HomeCare Corporation (NASDAQ: ADUS) presents a compelling opportunity for investors within the healthcare sector, particularly in the medical care facilities industry. With a market capitalization of approximately $1.99 billion,..

Veracyte, Inc. (VCYT) Stock Analysis: Exploring a 14.67% Potential Upside in the Healthcare Diagnostics Sector

For investors eyeing opportunities in the healthcare diagnostics sector, Veracyte, Inc. (NASDAQ: VCYT) presents a compelling case. With a market capitalization of $3.29 billion, Veracyte’s innovative diagnostic solutions are making..

LeMaitre Vascular, Inc. (LMAT) Stock Report: Analyzing 17.44% Potential Upside with Strong Revenue Growth

LeMaitre Vascular, Inc. (NASDAQ: LMAT) has captured investor attention with its robust presence in the medical instruments and supplies sector. With a market capitalization of $2 billion, this Burlington, Massachusetts-based..

Organon & Co. (OGN) Stock Analysis: Evaluating the 6.82% Potential Upside in the Healthcare Sector

For investors with a keen eye on the healthcare sector, Organon & Co. (NYSE: OGN) presents an intriguing prospect. This Jersey City-headquartered company, with a rich history dating back to..

Disc Medicine, Inc. (IRON) Stock Analysis: A 72% Upside Potential in the Biotech Sector

Disc Medicine, Inc. (NASDAQ: IRON), a promising player in the biotechnology sector, has captured the attention of investors with its strong growth potential and innovative focus on hematologic diseases. With..

Catalyst Pharmaceuticals, Inc. (CPRX) Stock Analysis: A 53.56% Potential Upside Beckons Investors

Catalyst Pharmaceuticals, Inc. (CPRX), a prominent player in the biotechnology sector, is capturing investor attention with its significant potential upside of 53.56%. The company, which focuses on developing and commercializing..

Ardent Health, Inc. (ARDT) Stock Analysis: Exploring a 53.88% Potential Upside

Ardent Health, Inc. (NASDAQ: ARDT), a prominent player in the healthcare sector, continues to captivate investor attention with its robust network of hospitals and clinics across the United States. With..

Certara, Inc. (CERT) Stock Analysis: Unveiling a 30% Upside Potential with Strong Buy Ratings

Certara, Inc. (NASDAQ: CERT), a stalwart in the healthcare industry, stands out as a noteworthy contender for investors seeking exposure to the health information services sector. With a market capitalization..

Twist Bioscience Corporation (TWST) Stock Analysis: Navigating a Complex Landscape with Strategic Growth Prospects

Twist Bioscience Corporation (NASDAQ: TWST) operates at the cutting edge of synthetic DNA manufacturing, a sector with promising applications across multiple industries. From therapeutics and diagnostics to data storage and..

Perrigo Company plc (PRGO): Investor Outlook – Analyzing a 39.72% Potential Upside in the Healthcare Sector

Perrigo Company plc (NYSE: PRGO), a prominent player in the healthcare sector, has been making waves with a potential upside of 39.72% based on current analyst targets. Headquartered in Dublin,..

Envista Holdings Corporation (NVST): Investor Outlook Amid 11.5% Revenue Growth and Strategic Positioning in Dental Products

Envista Holdings Corporation (NYSE: NVST) stands at the forefront of the healthcare sector, carving a niche in the medical instruments and supplies industry with its extensive range of dental products...

US Broker Ratings

US Broker Ratings

FTSE 100

Funds